FDA inspection
Co-Innovation Biotech Co., Ltd.: FDA inspection ending Nov 14, 2024
FDA inspection 1256044 · Voluntary Action Indicated (VAI) · Guangzhou
Key facts
| Inspection ID | 1256044 |
|---|---|
| Firm | Co-Innovation Biotech Co., Ltd. |
| FEI number | 3010220539 |
| Address | Econonic And Technological Development, No. 9 Baihe 3rd Street; East Zone |
| City | Guangzhou |
| Country | China |
| Fiscal year | 2025 |
| Inspection end date | Nov 14, 2024 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Postmarket Assurance: Devices |
| Product type | Devices |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data